Curium US
Clinical trials sponsored by Curium US, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New scan could help doctors spot hidden prostate cancer spread Results expected Sep 2026 (estimated)
-
Can a radioactive 'Smart Bomb' outsmart advanced prostate cancer?
Disease control OngoingThis phase 3 trial is testing whether a new type of targeted radiation therapy, called 177Lu-PSMA-I&T, can slow the progression of metastatic castration-resistant prostate cancer better than standard hormone therapy. The study enrolls men with prostate cancer that has spread and …
Phase 3 • Sponsor: Curium US LLC • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New scan could help doctors spot hidden prostate cancer spread
Diagnosis OngoingThis study tests a new type of PET/CT scan using a radioactive tracer called copper Cu 64 PSMA I&T to see if it can accurately find prostate cancer that has spread to pelvic lymph nodes. About 439 men with newly diagnosed, aggressive prostate cancer who are planning to have their…
Phase 3 • Sponsor: Curium US LLC • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC